Companies / Sangamo Therapeutics, Inc. / Activity
Activity — Sangamo Therapeutics, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common stock | $1.31M | +5.3M | 5,288,097 1.28% of shares | low |
| Q1 2026 as of | Sanders Morris Harris LLC 13F manager | New | Common stock | $164.9K | +668K | 668,000 0.16% of shares | low |
| Q1 2026 as of | Mak Capital One LLC 13F manager | New | Common stock | $138.6K | +562K | 561,538 0.14% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common stock | $76.0K | +304K | 303,862 0.07% of shares | low |
| Q1 2022 as of | Leonteq Securities AG 13F manager | New | Common stock | $40.7K | +7K | 7,000 <0.01% of shares | low |
| Q1 2026 as of | Equitable Holdings, Inc. 13F manager | New | Common stock | $5.4K | +13K | 12,848 <0.01% of shares | low |
| Q1 2025 as of | Leonteq Securities AG 13F manager | New | Common stock | $1.5K | +2K | 2,262 <0.01% of shares | low |
| Q4 2025 as of | Prestige Wealth Management Group LLC 13F manager | New | Common stock | $126 | +300 | 300 <0.01% of shares | low |